Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous 'L-ornithine L-aspartate' in Reversal of Overt Acute Hepatic Encephalopathy in Patients With Liver Cirrhosis: a Prospective, Randomized, Double-blind, Placebo Controlled Trial

NCT01722578 is registered in ClinicalTrials.gov with Dayanand Medical College and Hospital as lead sponsor.

NCT NCT01722578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01722578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous 'L-ornithine L-aspartate' in Reversal of Overt Acute Hepatic Encephalopathy in Patients With Liver Cirrhosis: a Prospective, Randomized, Double-blind, Placebo Controlled Trial
Lead sponsor
Dayanand Medical College and Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
January 31, 2017
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis of liver, hepatic encephalopathy